Literature DB >> 29705191

Mild fetal ventriculomegaly: diagnosis, evaluation, and management.

Nathan S Fox1, Ana Monteagudo1, Jeffrey A Kuller1, Sabrina Craigo1, Mary E Norton1.   

Abstract

Ventriculomegaly is defined as dilation of the fetal cerebral ventricles and is a relatively common finding on prenatal ultrasound. The purpose of this document is to review the diagnosis, evaluation, and management of mild fetal ventriculomegaly. When enlargement of the lateral ventricles (≥10 mm) is identified, a thorough evaluation should be performed, including detailed sonographic evaluation of fetal anatomy, amniocentesis for karyotype and chromosomal microarray analysis, and a workup for fetal infection. In some cases, fetal magnetic resonance imaging may identify other central nervous system abnormalities and should be considered when this technology as well as expert interpretation is available. Follow-up ultrasound examination should be performed to assess for progression of the ventricular dilation. In the setting of isolated ventriculomegaly of 10-12 mm, the likelihood of survival with normal neurodevelopment is >90%. With moderate ventriculomegaly (13-15 mm), the likelihood of normal neurodevelopment is 75-93%. The following are Society for Maternal-Fetal Medicine recommendations: We suggest that ventriculomegaly be characterized as mild (10-12 mm), moderate (13-15 mm), or severe (>15 mm) for the purposes of patient counseling, given that the chance of an adverse outcome and potential for other abnormalities are higher when the ventricles measure 13-15 mm vs 10-12 mm (GRADE 2B); we recommend that diagnostic testing (amniocentesis) with chromosomal microarray analysis should be offered when ventriculomegaly is detected (GRADE 1B); we recommend testing for cytomegalovirus and toxoplasmosis when ventriculomegaly is detected, regardless of known exposure or symptoms (GRADE 1B); we suggest that magnetic resonance imaging be considered in cases of mild or moderate fetal ventriculomegaly when this modality and expert radiologic interpretation are available; magnetic resonance imaging is likely to be of less value if the patient has had a detailed ultrasound performed by an individual with specific experience and expertise in sonographic imaging of the fetal brain (GRADE 2B); we recommend that timing and mode of delivery be based on standard obstetric indications (GRADE 1C); we recommend that with isolated mild ventriculomegaly of 10-12 mm, after a complete evaluation, women be counseled that the outcome is favorable, and the infant is likely to be normal (GRADE 1B); we recommend that with isolated moderate ventriculomegaly of 13-15 mm, after a complete evaluation, women be counseled that the outcome is likely to be favorable but that there is an increased risk of neurodevelopmental disabilities (GRADE 1B).
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  dilated cerebral ventricles; fetal brain; fetal magnetic resonance imaging; hydrocephalus; ventriculomegaly

Mesh:

Year:  2018        PMID: 29705191     DOI: 10.1016/j.ajog.2018.04.039

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

Review 1.  Imaging of fetal ventriculomegaly.

Authors:  David M Mirsky; Nicholas V Stence; Andria M Powers; Andra L Dingman; Ilana Neuberger
Journal:  Pediatr Radiol       Date:  2020-11-30

2.  Diagnosis, management, and neurodevelopmental outcomes of fetal hydrocephalus: an observational prospective study.

Authors:  Ru Wang; YiLing Ding; Mengyuan Yang; Weisi Lai
Journal:  Childs Nerv Syst       Date:  2021-09-12       Impact factor: 1.475

3.  Epidemiology of fetal cerebral ventriculomegaly and evaluation of chromosomal microarray analysis versus karyotyping for prenatal diagnosis in a Chinese hospital.

Authors:  Jun-Ling Yi; Wei Zhang; Da-Hua Meng; Li-Jie Ren; Jin Yu; Yi-Liang Wei
Journal:  J Int Med Res       Date:  2019-08-19       Impact factor: 1.671

4.  Evaluation of Hemodynamic Changes in Fetuses With Isolated Mild-to-Moderate Ventriculomegaly by Transabdominal Ultrasound.

Authors:  Lijuan Sun; Lina Zhang; Na Zhang; Jijing Han; Zhen Li; Tiejuan Zhang; Ling Yao; Yuqing Ma; Li Wang; Yan Liu; Cuixia Guo; Qingqing Wu
Journal:  J Ultrasound Med       Date:  2019-08-25       Impact factor: 2.153

5.  Fetal, neonatal, and infant outcomes associated with maternal Zika virus infection during pregnancy: A systematic review and meta-analysis.

Authors:  Marlos Melo Martins; Antonio José Ledo Alves da Cunha; Jaqueline Rodrigues Robaina; Carlos Eduardo Raymundo; Arnaldo Prata Barbosa; Roberto de Andrade Medronho
Journal:  PLoS One       Date:  2021-02-19       Impact factor: 3.240

6.  Comprehensive Assessment of Fetal Bilateral Ventriculomegaly Based on Genetic Disorders, Cytomegalovirus Infection, Extra Prenatal Imaging and Pregnancy Outcomes in a Tertiary Referral Center.

Authors:  Danhua Guo; Deqin He; Qingmei Shen; Na Lin; Shuqiong He; Yifang Dai; Ying Li; Liangpu Xu; Xiaoqing Wu
Journal:  Int J Gen Med       Date:  2021-11-05

Review 7.  Perinatal post-mortem magnetic resonance imaging (MRI) of the central nervous system (CNS): a pictorial review.

Authors:  Carlos Pérez-Serrano; Álvaro Bartolomé; Núria Bargalló; Carmen Sebastià; Alfons Nadal; Olga Gómez; Laura Oleaga
Journal:  Insights Imaging       Date:  2021-07-22

8.  Prenatal diagnosis of chromosomal aberrations by chromosomal microarray analysis in foetuses with ventriculomegaly.

Authors:  Jiamin Wang; Zhu Zhang; Qinqin Li; Hongmei Zhu; Yi Lai; Wei Luo; Shanling Liu; He Wang; Ting Hu
Journal:  Sci Rep       Date:  2020-11-27       Impact factor: 4.379

9.  Asymmetric cortical development and prognosis in fetuses with isolated mild fetal ventriculomegaly: an observational prospective study.

Authors:  Rong Zhu; Jun Ya Chen; Xin Lin Hou; Li Li Liu; Guo Yu Sun
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-10       Impact factor: 3.007

10.  Recurrent neonatal sepsis and progressive white matter injury in a premature newborn culture-positive for group B Streptococcus: A case report.

Authors:  Cheong-Jun Moon; Tae Hee Kwon; Kyung Sang Lee; Hyun-Seung Lee
Journal:  Medicine (Baltimore)       Date:  2021-06-25       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.